All In Biotech

Drug Trial Radar · NCT05021536

Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of AMX0035 Versus Placebo for 48-week Treatment of Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

Last checked: Nov 19, 2026Latest source record: Aug 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 664 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

664

Actual

Start

Oct 28, 2021

Primary completion

Jan 19, 2024

Study completion Jan 1, 2026

Sponsor

Lead sponsor
Amylyx Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Aug 25, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Phoenix Trial is a randomized double blind placebo controlled Phase III trial to evaluate the safety and efficacy of AMX0035 for treatment of ALS

Conditions

  • Amyotrophic Lateral Sclerosis

Interventions

  • PlaceboOther

    Matching Placebo Comparator

  • AMX0035Drug

    Proprietary formulation of taurursodiol and sodium phenylbutyrate

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) Slope ChangeTime frame: 48 weeks

Locations

69 sites in 12 countries. Site status is shown where the registry gives one.

  • Barrow Neurological Institute

    Phoenix, Arizona

  • University of Southern California

    Los Angeles, California

  • University of California Irvine

    Orange, California

  • California Pacific Medical Center Research Institute

    San Francisco, California

  • University of Colorado

    Aurora, Colorado

  • University of Florida

    Gainesville, Florida

  • University of South Florida

    Tampa, Florida

  • Emory University

    Atlanta, Georgia

  • Augusta University Neuroscience Center

    Augusta, Georgia

  • Northwestern University

    Chicago, Illinois

  • Johns Hopkins University School of Medicine Outpatient Center

    Baltimore, Maryland

  • Healey & AMG Center for ALS Research at Massachusetts General Hospital

    Boston, Massachusetts

  • University of Massachusetts

    Worcester, Massachusetts

  • Hennepin Healthcare Research Institute

    Minneapolis, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • Somnos Clinical Research

    Lincoln, Nebraska

  • Rutgers University

    New Brunswick, New Jersey

  • Columbia University

    New York, New York

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina

  • The Ohio State University

    Columbus, Ohio

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Lewis Katz School of Medicine at Temple University

    Philadelphia, Pennsylvania

  • Austin Neuromuscular Center

    Austin, Texas

  • Texas Neurology

    Dallas, Texas

  • Virginia Commonwealth University

    Henrico, Virginia

  • Swedish Neuroscience Institute

    Seattle, Washington

  • University of Washington

    Seattle, Washington

  • University Hospitals Leuven

    Leuven, Belgium

  • Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer Cellule Mutualisée de Recherche Clinique (CMRC)

    Bron, France

  • Hopital Gabriel Montpied Service de Neurologie

    Clermont-Ferrand, France

  • CHRU de Lille - Hôpital Roger Salengro

    Lille, France

  • CHU de Limoges - Hôpital Dupuytren

    Limoges, France

  • Hôpitaux Universitaires de Marseille Timone

    Marseille, France

  • CHU de Montpellier

    Montpellier, France

  • CHU Nice

    Nice, France

  • Hôpital de la Salpêtrière

    Paris, France

  • Le Centre Hospitalier Régional Universitaire de Tours

    Tours, France

  • Charité - Universitätsmedizin Berlin

    Berlin, Germany

  • Uniklinikum Dresden

    Dresden, Germany

Showing 40 of 69 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.